https://belaydiagnostics.com/publications/clinician-perspectives-on-the-clinical-utility-of-belay-summit-2-0-cerebrospinal-fluid-test-a-mixed-methods-study/ 2026-09-21T14:24:57+00:00 https://belaydiagnostics.com/publications/rare-mutations-detection-massively-parallel-sequencing/ 2026-08-25T12:20:05+00:00 https://belaydiagnostics.com/publications/rare-mutations-copy-number-methylation-csf-dna-study/ 2026-08-22T19:15:15+00:00 https://belaydiagnostics.com/publications/low-frequency-dna-variants-targeted-sequencing-study/ 2026-08-22T19:14:41+00:00 https://belaydiagnostics.com/publications/circulating-tumor-dna-early-late-stage-cancer-detection/ 2026-08-22T19:14:14+00:00 https://belaydiagnostics.com/publications/tert-promoter-mutations-gliomas-study/ 2026-08-22T19:13:46+00:00 https://belaydiagnostics.com/publications/the-genetic-landscape-of-the-childhood-cancer-medulloblastoma/ 2026-08-22T19:13:08+00:00 https://belaydiagnostics.com/publications/copy-number-methylation-mutation-same-dna-molecules/ 2026-08-22T19:03:53+00:00 https://belaydiagnostics.com/publications/tumor-dna-csf-brain-spinal-cord-tumors-study/ 2026-08-22T19:02:46+00:00 https://belaydiagnostics.com/publications/cic-fubp1-mutations-oligodendroglioma-study/ 2026-08-22T16:23:53+00:00 https://belaydiagnostics.com/publications/csf-liquid-biopsy-leptomeningeal-metastasis-egfr-lung-cancer/ 2026-08-22T15:51:33+00:00 https://belaydiagnostics.com/publications/mgmt-promoter-methylation-csf-analytical-validation/ 2026-08-22T15:50:15+00:00 https://belaydiagnostics.com/publications/choroid-plexus-metastasis-renal-cell-carcinoma-case-report/ 2026-08-22T15:48:26+00:00 https://belaydiagnostics.com/publications/csf-genomic-profiling-cns-tumors-meta-analysis/ 2026-08-22T15:46:33+00:00 https://belaydiagnostics.com/publications/csf-dna-variant-detection-cns-cancer-validation-study/ 2026-08-22T15:43:31+00:00 https://belaydiagnostics.com/publications/csf-tumor-dna-idh-mutant-brainstem-glioma/ 2026-08-22T15:40:25+00:00 https://belaydiagnostics.com/publications/csf-tumor-dna-breast-cancer-brain-metastasis/ 2026-08-22T15:36:59+00:00 https://belaydiagnostics.com/publications/csf-dna-monitoring-leptomeningeal-disease-lung-cancer/ 2026-08-22T15:35:36+00:00 https://belaydiagnostics.com/publications/summit-csf-liquid-biopsy-validation-study/ 2026-08-22T15:34:10+00:00 https://belaydiagnostics.com/publications/cns-lymphoma-csf-liquid-biopsy-clinical-impact-study/ 2026-08-22T15:32:26+00:00 https://belaydiagnostics.com/publications/summit-clinical-utility-utsw-study/ 2026-08-22T15:30:16+00:00 https://belaydiagnostics.com/publications/leptomeningeal-disease-csf-liquid-biopsy/ 2026-08-22T15:26:28+00:00 https://belaydiagnostics.com/publications/clinical-validation-of-the-belay-ascent-test-to-report-on-chromosomal-arm-level-aneuploidy-and-gene-level-copy-number-variants-in-cerebrospinal-fluid-using-low-pass-whole-genome-sequencing/ 2026-08-22T15:25:28+00:00 https://belaydiagnostics.com/publications/analytical-validation-of-quantitative-polymerase-chain-reaction-and-belay-ascent-low-pass-whole-genome-sequencing-to-report-on-gene-copy-number-variants-in-cerebrospinal-fluid-tumor-deri/ 2026-08-22T15:24:15+00:00 https://belaydiagnostics.com/news/csf-liquid-biopsy-summit-2-0-clinical-impact/ 2026-07-21T19:40:44+00:00 https://belaydiagnostics.com/news/belay-announces-update-to-nccn-guidelines-to-recommend-csf-based-genomic-profiling-in-biopsy-infeasible-high-grade-gliomas/ 2026-06-17T14:36:15+00:00 https://belaydiagnostics.com/news/summit-93-percent-clinical-decisions-cns-cancer/ 2026-05-29T18:16:03+00:00 https://belaydiagnostics.com/news/summit-csf-liquid-biopsy-validation/ 2026-05-12T20:45:34+00:00 https://belaydiagnostics.com/news/belay-diagnostics-announces-the-validation-of-vantage-assay-for-evaluation-of-mgmt-promoter-methylation-in-cerebrospinal-fluid-csf/ 2026-05-12T19:09:27+00:00 https://belaydiagnostics.com/news/csf-liquid-biopsy-leptomeningeal-disease/ 2026-05-01T19:12:44+00:00 https://belaydiagnostics.com/news/csf-liquid-biopsy-cns-lymphoma-clinical-impact/ 2026-04-07T16:57:29+00:00 https://belaydiagnostics.com/news/belay-diagnostics-partners-with-genomoncology-to-support-high-performance-liquid-biopsy-test-for-central-nervous-system-cancer-detection/ 2026-03-11T22:05:39+00:00 https://belaydiagnostics.com/news/belay-diagnostics-announces-us-commercial-launch-of-summit-breakthrough-csf-testing-for-cns-cancer-detection-and-management/ 2026-03-11T22:05:19+00:00 https://belaydiagnostics.com/news/nih-award-multi-omic-csf-assay-for-the-diagnosis-of-brain-cancers/ 2026-03-11T22:05:19+00:00